Quidel Corp (QDEL):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Quidel Corp (QDEL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7011
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥69,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥103,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Quidel Corp (Quidel) develops, manufactures and markets rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays; molecular assays; virology products including traditional cell lines, specimen collection devices, media and controls; and specialty products including metabolic bone markers and enzyme linked immunosorbent assays (ELISA) and reagents. The company offers its products to physician offices, hospitals, clinical and reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Quidel distributes its products through direct sales force and a network of national and regional distributors. It has a direct presence in the US and Germany. Quidel is headquartered in San Diego, California, the US.

Quidel Corp (QDEL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Quidel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Quidel Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Quidel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Quidel Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Quidel Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Quidel Corp, Medical Equipment, Deal Details 10
Asset Purchase 10
Quidel Acquires Triage and BNP Business from Alere 10
Quidel Acquires InflammaDry and AdenoPlus Diagnostic Businesses from Rapid Pathogen Screening for USD14 Million 12
Partnerships 13
InGen BioSciences Enters Into Distribution Agreement With Quidel 13
InGen BioSciences Enters Into Distribution Agreement With Diagnostic Hybrids 14
Debt Offering 15
Quidel Raises USD172.5 Million in Public Offering of 3.25% Senior Notes Due 2020 15
Acquisition 17
Quidel Acquires AnDiaTec 17
Quidel Acquires BioHelix, Molecular Diagnostic Company, For US$10 Million 18
Quidel Corp – Key Competitors 19
Quidel Corp – Key Employees 20
Quidel Corp – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 07, 2018: Quidel reports second quarter 2018 financial results 22
May 08, 2018: Quidel Announces First Quarter 2018 Financial Results 24
Feb 21, 2018: Quidel Reports Fourth Quarter and Full Year 2017 Financial Results 26
Nov 01, 2017: Quidel Reports Third Quarter 2017 Financial Results 28
Jul 26, 2017: Quidel Reports Second Quarter 2017 Financial Results 30
Apr 24, 2017: Quidel Reports First Quarter 2017 Financial Results 32
Feb 08, 2017: Quidel Reports Fourth Quarter and Full Year 2016 Financial Results 33
Jan 06, 2017: Quidel Announces Preliminary Revenue for Fourth Quarter 2016 35
Other Significant Developments 36
Feb 19, 2018: Quidel to establish new Business Service Centre in Galway city 36
Nov 27, 2017: Quidel Confident in Legal Strength and Validity of Supply Agreement with Beckman Coulter to Sell BNP Assay Assets 37
Jan 23, 2017: Quidel Announces Modification of Revenue Reporting Categories 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Quidel Corp, Medical Equipment, Key Facts, 2017 2
Quidel Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Quidel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Quidel Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Quidel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Quidel Corp, Deals By Market, 2012 to YTD 2018 8
Quidel Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Quidel Acquires Triage and BNP Business from Alere 10
Quidel Acquires InflammaDry and AdenoPlus Diagnostic Businesses from Rapid Pathogen Screening for USD14 Million 12
InGen BioSciences Enters Into Distribution Agreement With Quidel 13
InGen BioSciences Enters Into Distribution Agreement With Diagnostic Hybrids 14
Quidel Raises USD172.5 Million in Public Offering of 3.25% Senior Notes Due 2020 15
Quidel Acquires AnDiaTec 17
Quidel Acquires BioHelix, Molecular Diagnostic Company, For US$10 Million 18
Quidel Corp, Key Competitors 19
Quidel Corp, Key Employees 20
Quidel Corp, Other Locations 21
Quidel Corp, Subsidiaries 21

List of Figures
Quidel Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Quidel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Quidel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Quidel Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Quidel Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Quidel Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Quidel Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Quidel Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Quidel Corp (QDEL):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ratchaburi Electricity Generating Holding Public Co Ltd:発電所・企業SWOT分析
    Ratchaburi Electricity Generating Holding Public Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT an …
  • KYORIN Holdings Inc (4569):製薬・医療:M&Aディール及び事業提携情報
    Summary KYORIN Holdings Inc (KYORIN), formerly known as KYORIN Co.,Ltd., is a holding company. Its business activities include controlling, administering and supporting companies, which conduct various businesses by holding the shares of those companies. The company through its subsidiaries carries …
  • Actuate Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Actuate Therapeutics Inc (Actuate Therapeutics) is a biopharmaceutical company that offers development of novel compounds for the treatment of cancer and inflammatory diseases. The company’s lead compound 9-ING-41 is under evaluation for anti-tumor activity in various vivo models. It also de …
  • Smrt Corporation Ltd.
    Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SonarMed Inc:医療機器:M&Aディール及び事業提携情報
    Summary SonarMed Inc (SonarMed) is a medical device company that develops endotrachael systems used for the inhalation and ventilation assistance patients. The company offers products such as artificial respiratory, endotrachael tubes, biomedical acoustics, SonarMed Airwave, medical devices, disposa …
  • Theralase Technologies Inc (TLT):企業の財務・戦略的SWOT分析
    Summary Theralase Technologies Inc (Theralase) is a clinical stage pharmaceutical company which specializes in design, development, and manufacturing of laser based technologies used in wide range of bio-destructive and bio-simulative clinical applications. The company is focused on the development …
  • Chiyoda Corporation:企業の戦略・SWOT・財務情報
    Chiyoda Corporation - Strategy, SWOT and Corporate Finance Report Summary Chiyoda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Varian Medical Systems Inc (VAR):企業の財務・戦略的SWOT分析
    Varian Medical Systems Inc (VAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Mitsui E&S Holdings Co., Ltd. (7003):企業の財務・戦略的SWOT分析
    Mitsui E&S Holdings Co., Ltd. (7003) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • TECSYS Inc. (TCS):企業の財務・戦略的SWOT分析
    TECSYS Inc. (TCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Scotiabank Peru S.A.A.
    Scotiabank Peru S.A.A. - Strategy, SWOT and Corporate Finance Report Summary Scotiabank Peru S.A.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Litha Healthcare Group Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Litha Healthcare Group Ltd (Litha Healthcare), formerly Myriad Medical Holdings Limited, a subsidiary of Endo International plc is a healthcare company that provides its services to public and private hospitals, pharmacies, general, allied practitioners, and government healthcare programmes. …
  • Coloplast AS (COLO B):企業の財務・戦略的SWOT分析
    Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sanquin Blood Supply Foundation-医療機器分野:企業M&A・提携分析
    Summary Sanquin Blood Supply Foundation (Sanquin) is a blood bank that supplies blood and promotes transfusion medicine. The organization offers plasma and blood products. Its services comprise diagnostic, consulting, reagents, DNA paternity testing, pharmaceutical, immuno monitoring services, biolo …
  • Tzamal Medical Group Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Tzamal Medical Group Ltd (Tzamal Medical) is a medical device company that manufactures and markets medical equipment, implants, disposables, surgical instruments and veterinary drugs. The company’s products include disposable products, patient monitor equipment and patient self testing equi …
  • Territorial Generating Company #2 (TGKB):企業の財務・戦略的SWOT分析
    Territorial Generating Company #2 (TGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Clalit Health Services:企業の戦略的SWOT分析
    Clalit Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Exide Technologies:企業の戦略的SWOT分析
    Exide Technologies - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • TAG Oil Ltd (TAO):企業の財務・戦略的SWOT分析
    Summary TAG Oil Ltd (TAG Oil) is an oil and gas exploration company engaged in the production of crude oil and natural gas across Canada. The company owns and operates oil and gas properties in Surat Basin and Taranaki Basin. The Taranaki Basin is located to the North Island of New Zealand. The comp …
  • Torrent Pharmaceuticals Ltd (TORNTPHARM):製薬・医療:M&Aディール及び事業提携情報
    Summary Torrent Pharmaceuticals Ltd (Torrent) manufactures and markets branded and unbranded generic pharmaceuticals. It provides products in cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. Also, the company has presence in nephrol …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆